ALS Biotech Firm Amylyx Pharmaceuticals Launches Nasdaq IPO
Clinical-stage biopharmaceutical company Amylyx Pharmaceuticals is looking to go public on the Nasdaq Global Select Market. The firm announced today
Read moreClinical-stage biopharmaceutical company Amylyx Pharmaceuticals is looking to go public on the Nasdaq Global Select Market. The firm announced today
Read more